— Agilent Technologies, Inc. (NYSE: A) reported its first-quarter 2020 adjusted earnings of $0.81 per share, up 7% year-over-year. This came in line with the analysts’ expectations.
— Revenue grew by 5.7% to $1.36 billion versus $1.35 billion expected.
— Life Sciences and Applied Markets Group sales rose 5% on continued strength in Environmental & Forensics markets and stable Chemical & Energy.
— Agilent CrossLab Group grew by 6% on continued performance across both services and consumables.
— Diagnostics and Genomics Group saw 6% growth aided by continued strong Nucleic Acids Solutions Division, high single-digit growth in the Next-Generation Sequencing portfolio and mid-single-digit growth in Pathology related businesses.
— Looking ahead into the second quarter of 2020, the company expects revenue in the range of $1.28-1.32 billion and adjusted earnings of $0.72-0.76 per share. Analysts expect EPS of $0.79 on revenue of $1.34 billion.
— The estimated impact of Coronavirus in China of about $10 million revenue deferred into Q2, mostly in Life Sciences and Applied Markets Group.
— For the full year 2020, the company still predicts revenue in the range of $5.50-5.55 billion and adjusted earnings of $3.38-3.43 per share. The consensus estimates EPS of $3.42 on revenue of $5.54 billion.